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Abstract
Background: We assessed performance of 6 aspiration catheters for distal embolization using 
a distal protection filter in an in vitro experiment. In acute myocardial infarction, a distal pro-
tection filter is used for lesions likely to induce a distal embolism. Which aspiration cathether 
is most effective when used with a distal protection filter remains still unclear.
Methods: A 0.5-cm3 bolus of gelatin as a model of stagnant pools of coronary plaque debris 
was captured in the distal protection filter and aspirated by 6 aspiration catheters. We meas-
ured and compared the length of the suspended embolus matter.
Results: Among the 6 catheters evaluated, the use of the Export Advance catheter (Medtronic) 
resulted in significantly shorter lengths of the suspended embolus matter compared to the use 
of the TVAC II (Nipro), Thrombuster III SL (Kaneka), and Rebirth Pro (Goodman) catheters  
(p < 0.01). The residual embolus matter in all cases had drained distally to the distal protec-
tion filter when the filter was retrieved.
Conclusions: The use of the Export Advance catheter showed better performance using a dis-
tal protection filter in this in vitro experiment, and its use might be more effective in preventing 
distal embolisms in combination with a distal protection filter. (Cardiol J 2016; 23, 6: 667–672)
Key words: percutaneous coronary intervention, distal embolization, acute  
myocardial infarction, aspiration catheters, distal protection device and  
filter no-reflow
Introduction
The no-reflow phenomenon indicates a peri-
procedural myocardial infarction (MI) even with the 
successful dilatation of occluded arteries, resulting in 
a poor prognosis [1, 2]. The reported frequency of the 
no-reflow phenomenon was 13% in patients with an 
ST-segment elevation MI (STEMI) who had under-
gone a primary percutaneous coronary intervention 
(PCI) [2, 3]. The main cause of the no-reflow phenom-
enon is a distal embolism due to thrombi and/or debris 
from a ruptured plaque [4]. A distal embolism during 
a primary PCI results in a reduction of myocardial 
perfusion and poor clinical outcomes [5–7]. Various 
distal protection filters and aspiration catheters were 
developed to prevent distal embolisms.
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However, the clinical benefits of the distal 
protection filters and aspiration catheters during 
primary PCI in patients with STEMI have been 
a matter of discussion. The phenomenon of filter 
no-reflow has been reported as one of the causes 
of failure in accomplishing successful Thrombolysis 
in Myocardial Infarction (TIMI)-3 flow when using 
these embolism-prevention devices [8, 9].
We speculated that the use of an aspiration 
catheter device and a distal protection filter device 
may not be enough to retrieve embolic debris and 
aspirate the suspended embolus matter in the 
proximal portion of the distal protection filter de-
vice when filter no-reflow is observed. Although 
several types of aspiration catheters have been 
developed, it is not clear how much embolus matter 
any of the aspiration catheters can aspirate with 
the use of the distal protection filter.
In the present study, we investigated the 
efficacy of six aspiration catheters for retrieving 
suspended embolus matter in a proximal portion 
of a distal protection filter and how much of the 
embolus matter is left behind after aspiration.
Methods
The experiment was performed using a simu-
lated vascular system (Wet Track Glass Model, 
Medtronic, Minneapolis, MN). The system, made 
of glass and a polyvinyl chloride tube (4 mm dia.), 
produces a steady flow that mimics the human 
cardiovascular system. The flow velocity was 
3.38 m/s (Fig. 1) [10].
A Filtrap distal protection filter (5.0 mm dia., 
Nipro, Osaka, Japan) was used. The device has 
a 35-mm-long distal radiopaque floppy guidewire with 
a 1.15-mm dia. distal tip fixed in a spindle-shaped 
spiral wire basket with a porous polyurethane 
filter membrane (Fig. 1). The filter was delivered 
to the middle of the simulated vascular tube. As 
a model of stagnant pools of coronary plaque debris, 
0.5 cm3 of brown gelatin was injected into the tube 
by the aspiration catheter. This amount of gelatin 
was sufficient to obstruct the simulated vascular 
flow through the tube. The brown gelatin was soft 
enough to change the shape. The embolus matter 
was captured in Filtrap by the artificial flow and 
was aspirated by each aspiration catheter device 
through the original syringe packaged with the 
aspiration catheter. The length of the suspended 
embolus matter was defined as the proximal edge 
of the brown gelatin from the Filtrap’s distal end 
and was measured for each sample (Fig. 2).
Six aspiration catheters were evaluated: Ex-
port Advance (Medtronic), Thrombuster III SL/GR 
(Kaneka Medix, Osaka, Japan), Eliminate 3 (Ter-
umo, Tokyo), TVAC II (Nipro, Osaka, Japan), and 
Rebirth Pro (Goodman, Aichi, Japan). The length of 
the tip, the length from the tip to the distal end of 
the aspiration port, and the aspiration lumen area 
were originally measured by digital venire caliper 
for each catheter (Fig. 3).
The experiment was performed 9 times for 
each catheter, with 3 interventional cardiologists 
(A, B and C) each executing 3 procedures per aspi-
ration device. The length of each of the suspended 
emboli was measured independently by 2 observ-
ers. The value reported for each catheter is the 
average of the measurements from 2 observers.
Statistical analysis
Comparisons between aspiration catheters 
were made using the Kruskal-Wallis test. P-values 
< 0.05 were considered significant. All numeri-
cal values are expressed as the mean ± standard 
deviation. An intercorrelation coefficient was used 
to determine the inter-observer agreement of 
2 observers. Spearman’s rank-correlation coeffi-
cient was used to test the agreement between the 
length from the tip to the distal end of the aspira-
tion port and the length of the suspended embolus 
matter. Statistical analyses were performed using 
SPSS (Statistical Package for Social Science) soft-
ware for Windows version 16.0 (SPSS, Chicago, IL).
Figure 1. Simulated vascular system (Wet Track Glass 
Model, Medtronic). The system is made of glass and 
a polyvinyl chloride tube and produced a continuous 
flow that mimics the human cardiovascular system. The 
motor that creates the steady current is indicated by the 
black arrow. The location at which Filtrap is deployed in 
the simulated vascular tube is shown by the white arrow.
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Results
The results are presented in Table 1. The Ex-
port Advance catheter has the shortest length of 
the tip and shortest distance from the tip to the dis-
tal end of the aspiration port compared to the other 
five catheters. The Thrombuster III GR catheter 
has the largest aspiration lumen area compared to 
the other catheters. The lengths of the suspended 
embolus matter for each aspiration catheter were: 
Export Advance, 15.4 ± 1.0 mm; Thrombuster III 
GR, 18.1 ± 1.2 mm; Eliminate 3, 18.4 ± 1.2 mm; 
TVAC II, 19.1 ± 1.5; Thrombuster III SL, 19.4 ± 
± 0.9 mm; and Rebirth Pro, 21.1 ± 2.2 mm.
Among the 6 aspiration catheters evaluated, 
the use of the Export Advance catheter tended to 
provide a shorter length of suspended embolus 
matter than the other catheters. The use of the 
Export Advance resulted in significantly shorter 
lengths of suspended embolus matter compared 
to the use of the TVAC II catheter, the Thrombus-
ter III SL catheter and the Rebirth Pro catheter 
(p < 0.01) (Fig. 4).
There were no significant differences in the 
measurements of the length of the suspended 
embolus matter in each aspiration catheter among 
Figure 2. Representative examples. Images immediately after aspiration by the Thrombuster III SL catheter and Export 
Advance catheter, respectively (A, D). The suspended embolic matter for the Thrombuster III SL catheter and Export 
Advance catheter, respectively (B, E). Final images of the retrieval of Filtrap with an expropriation catheter (C, F). 
Panels C and F are representative for all samples tested, as retrieving the distal protection device produced similar 
results. The length of the suspended embolus matter is indicated by the black star.
A
B
C
D
E
F
Figure 3. Schema of the aspiration device and measure-
ment. The lengths of “a” and “b” indicate the tip length 
and the length from the tip to the distal end of the 
aspiration port, respectively. The areas of “c” and “d” 
indicate the aspiration lumen area of the distal and the 
proximal ends, respectively.
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the 3 interventional cardiologists except TVAC II, 
which showed a significant difference in the pro-
cedures obtained by operators A and B (Fig. 4). 
The inter-observer agreement of 2 Observers for 
the measurement of the length of the suspended 
embolic matter was 0.995.
The suspended embolus matter in all cases 
had drained distally to Filtrap when the distal 
protection device was retrieved (Supplementary 
Video — see journal website).
Spearman’s rank-correlation coefficient also 
indicated a significant correlation between the 
length from the tip to the distal end of the aspira-
tion port and the length of suspended embolus 
matter (Fig. 5).
Discussion
The main finding of the study is that the use 
of the Export Advance catheter tended to provide 
a shorter length of the suspended embolus matter 
than other aspiration catheters. The same ability 
for aspiration was shown by the Export Advance 
catheter regardless of the operator’s experience. 
This is likely because the Export Advance catheter 
has the shortest distal tip among the 6 catheters 
tested. The shorter distal tip of aspiration cath-
eter can aspirate suspended embolus matter most 
nearby distal protection device.Ta
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Figure 4. The length of the suspended embolus mat-
ter in the distal protection filter after the use of each 
aspiration catheter; *p < 0.01 compared to the use of 
the TVAC II, the Thrombuster III SL and the Rebirth Pro 
catheters; star — significantly different between Opera-
tors A and B.
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Our results also showed that the residual em-
bolus matter, which could not be aspirated by any of 
the aspiration catheters, drained to the distal site 
of the Filtrap distal protection filter. This result 
may reflect one of the mechanisms potentially 
underlying the inability to prevent distal emboliza-
tion in STEMI with a distal protection filter and an 
aspiration device.
In clinical practice, despite the use of a distal 
protection device and an aspiration device, same 
cases showed severe final TIMI flow grade 0 or 1 
for STEMI [11]. Several recent clinical trials dem-
onstrated that the routine therapy of intracoronary 
aspiration thrombectomy and distal protection 
during primary PCI for acute MI has not improved 
clinical outcomes despite the removal of debris, ex-
cept in cases with a high risk of distal embolization 
[11, 12]. At present, the distal protection device is 
not recommended to be used as routine adjunctive 
therapy in primary PCI procedures with stenting in 
patients with a STEMI in the native circulation, or 
in the routine performance of thrombus aspiration 
in patients undergoing a primary PCI.
Recent data suggest that a primary PCI with 
thrombus aspiration in MI patients was more likely 
to result in a higher TIMI grade in the infarct-
related artery and a lower in-hospital mortality 
rate compared to primary PCI without aspiration 
[13]. Moreover, another report demonstrated that 
distal protection during PCI effectively retrieved 
the embolic debris and preserved the index of mi-
crocirculatory resistance in patients with an acute 
anterior STEMI [14]. Embolic protection devices 
are designed to be able to retrieve atherothrom-
botic debris and prevent its distal embolisation, 
but their effect on clinical outcomes has not been 
established, except for saphenous vein bypass 
grafts [6, 7, 15–17].
Due to the fact that we encounter cases that 
result in coronary no-reflow among patients with 
eccentric plaques, positive remodeling and lipid-
rich plaque with attenuation regardless of whether 
STEMI is present, we consider it reasonable to 
conduct an aspiration thrombectomy in patients 
with a large thrombus burden, and the use of 
a distal protection device in patients with ruptured 
plaque likely leads to distal embolism [3, 6, 22]. Al-
though no-reflow can occur not only due to a distal 
embolism from a thrombus and/or ruptured plaque 
but also endothelial damage, tissue edema, tissue 
contracture, oxygen free radicals and intravascular 
plugging by fibrin, platelets or leukocytes [4], the 
appropriate use of aspiration catheters and distal 
protection devices might prevent at least coronary 
no-flow and achieve better coronary flow during 
a primary PCI. Clinicians should be aware of the 
varying performance of different aspiration devices 
and distal protection devices. The results of the 
present study demonstrated that the Export Ad-
vance aspiration catheter might be more effective 
than other aspiration catheters at present when 
filter no-reflow is observed.
The results of our present in vitro experiment 
demonstrated that as the length from the tip to the 
distal end of the catheter’s aspiration port shortens, 
the aspiration catheter can be used closer to the 
distal protection device and thus aspirate more of 
the suspended embolus matter captured in the dis-
tal protection device. When filter no-reflow occurs, 
an improved aspiration catheter that has a shorter 
tip length is needed.
In addition, the results of our study indicate 
that it is not possible to completely retrieve the 
debris and prevent distal embolization by using the 
current distal protection device. One of the reasons 
for this is that the residual embolus matter, which 
could not be aspirated by any of the aspiration 
catheters, drained to the distal site of the distal 
protection filter device. Our findings indicate that 
when the filter no-reflow phenomenon occurs, 
a shorter-tip aspiration catheter should be used 
to aspirate the debris to the very distal end of the 
filter device, to maximize the effect of the distal 
protection filter. In the future, the development of 
improved distal protection devices and aspiration 
devices with shorter tips may make it possible to 
completely aspirate a suspended embolus when 
filter no-reflow is present.
Figure 5. Spearman’s rank-correlation coefficient indi-
cated a significant correlation between the length from 
the tip to the distal end of the aspiration port and the 
length of suspended embolus matter (p < 0.001).
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Limitations of the study
The present study has several limitations. 
First, although the Filtrap embolic protection filter 
is frequently used in Japan (accounting for 92% of 
the distal protection devices in the field of coronary 
intervention in Japan), it may not be widely used 
elsewhere. In addition, we did not determine the 
relationships between other distal protection de-
vices and the aspiration catheters. We tested the 
efficacy of the aspiration catheters using Filtrap 
only. However, we consider that the basic struc-
ture of Filtrap is essentially the same as of other 
commercially available embolic protection filters 
such as FilterWire (EPI, Boston Scientific, Natick, 
MA), Angioguard (Cordis, Miami Lakes, FL), and 
Parachute (Tri-Med, Osaka, Japan).
Second, the embolus matter in this in vitro 
study was artificial gelatin. There may be sig-
nificant differences between such an experimental 
model and diseased human coronary arteries. It 
is necessary to test each aspiration catheter in 
multicenter clinical trials.
Conclusions
The use of the Export Advance aspiration 
catheter with the shortest length from the tip to 
the distal end of the aspiration port showed better 
performance with the distal protection filter in this 
in vitro experiment, and its use might be more ef-
fective to prevent distal embolisms in combination 
with a distal protection filter.
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